Article
Prevalence of HIV-1 drug resistance in Eastern European and Central Asian countries.
PloS one - 1 Jan 2000
Kirichenko Alina, Kireev Dmitry, Lopatukhin Alexey, Murzakova Anastasia, Lapovok Ilya, Saleeva Daria, Ladnaya Natalya, Gadirova Agigat, Ibrahimova Sabina, Safarova Aygun, Grigoryan Trdat, Petrosyan Arshak, Sarhatyan Tatevik, Gasich Elena, Bunas Anastasia, Glinskaya Iryna, Yurovsky Pavel, Nurov Rustam, Soliev Alijon, Ismatova Laylo, Musabaev Erkin, Kazakova Evgeniya, Rakhimova Visola, Pokrovsky Vadim
Abstract excerpt
BACKGROUND: Eastern Europe and Central Asia (EECA) is one of the regions where the HIV epidemic continues to grow at a concerning rate. Antiretroviral therapy (ART) coverage in EECA countries has significantly increased during the last decade, which can lead to an increase in the risk of emergence, transmission, and spread of HIV variants with drug resistance (DR) that cannot be controlled. Because HIV genotyping...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.